Endogenous Activators of Vanilloid Receptor
香草酸受体内源性激活剂
基本信息
- 批准号:6639818
- 负责人:
- 金额:$ 17.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-07-15 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Capsaicin or vanilloid receptors (VRs) participate in the sensation of thermal
and inflammatory pain. The cloned (VR1) and native VRs are non-selective cation
channels directly activated by noxious heat, extracellular protons and
vanilloid compounds. However, considerable attention has focused on identifying
other signaling pathways in VR activation, and this search has gained more
significance given the findings that VR1 is expressed in non-sensory tissue and
may mediate inflammatory rather than acute thermal pain. Protein kinase C (PKC)
plays an important role in pain signaling. Targeted deletion of PKC epsilon in
mice dramatically attenuates thermal- and acid-induced hyperalgesia. In turn,
activation of PKC epsilon potentiates heat-evoked currents in sensory neurons.
Further, the algesic peptide, bradykinin, potentiates heat responses, induces
depolarization and evokes secretion from vanilloid-sensitive neurons in a
PKC-dependent manner. Yet the molecular targets for these effects have not been
clearly identified. In this study we will test the hypothesis that the VR is
directly activated by PKC -mediated phosphorylation in the absence of any other
agonist. We propose that the pro-inflammatory peptide bradykinin induces VR
activity and that this occurs via the stimulation of PKC. We will also test the
hypothesis that in the phosphorylated state, a subthreshold stimulus will be
sufficient to maximally activate the VR. We propose that phosphorylation of the
channel functions as a gain control to modulate the efficacy and sensitivity of
VR activation. In this way a range of normally benign stimuli will become
potent activators of VRs. This research has important implications for
understanding the role of VRs in hyperalgesia, chronic pain and other
non-sensory functions.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LOUIS S PREMKUMAR其他文献
LOUIS S PREMKUMAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LOUIS S PREMKUMAR', 18)}}的其他基金
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
- 批准号:
7664827 - 财政年份:2009
- 资助金额:
$ 17.63万 - 项目类别:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
- 批准号:
8077896 - 财政年份:2009
- 资助金额:
$ 17.63万 - 项目类别:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
- 批准号:
8473195 - 财政年份:2009
- 资助金额:
$ 17.63万 - 项目类别:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
- 批准号:
8267070 - 财政年份:2009
- 资助金额:
$ 17.63万 - 项目类别:
A Novel Approach for Chronic Pain Treatment Using Resiniferatoxin
使用树脂毒素治疗慢性疼痛的新方法
- 批准号:
7869275 - 财政年份:2009
- 资助金额:
$ 17.63万 - 项目类别:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
糖尿病周围神经病变中的香草酸受体
- 批准号:
6930403 - 财政年份:2004
- 资助金额:
$ 17.63万 - 项目类别:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
糖尿病周围神经病变中的香草酸受体
- 批准号:
6820139 - 财政年份:2004
- 资助金额:
$ 17.63万 - 项目类别:
Vanilloid Receptors in Diabetic Peripheral Neuropathy
糖尿病周围神经病变中的香草酸受体
- 批准号:
7090665 - 财政年份:2004
- 资助金额:
$ 17.63万 - 项目类别:
Role of Vanilloid Receptors in Diabetic Peripheral Neuropathy
香草酸受体在糖尿病周围神经病变中的作用
- 批准号:
7682748 - 财政年份:2003
- 资助金额:
$ 17.63万 - 项目类别:
相似海外基金
Negative allosteric modulators for bradykinin B1 receptors
缓激肽 B1 受体的负变构调节剂
- 批准号:
10680762 - 财政年份:2023
- 资助金额:
$ 17.63万 - 项目类别:
Excitatory effect of bradykinin on intracardiac neurons
缓激肽对心内神经元的兴奋作用
- 批准号:
19K07287 - 财政年份:2019
- 资助金额:
$ 17.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of cleaving enzymes activities for bradykinin in hereditary angioedema
遗传性血管性水肿中缓激肽裂解酶活性分析
- 批准号:
19K17917 - 财政年份:2019
- 资助金额:
$ 17.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Augmentation of tumor-target delivery of nanomedicine by an acid-responsive N-(2-hydroxypropyl)methacrylamide-based polymer-bradykinin conjugate.
通过酸响应性 N-(2-羟丙基)甲基丙烯酰胺基聚合物-缓激肽缀合物增强纳米药物的肿瘤靶向递送。
- 批准号:
18K06773 - 财政年份:2018
- 资助金额:
$ 17.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of bradykinin receptor 2 in tPA stroke therapy
缓激肽受体 2 在 tPA 中风治疗中的作用
- 批准号:
9767297 - 财政年份:2018
- 资助金额:
$ 17.63万 - 项目类别:
Studies for the evaluation of bradykinin cleaving enzymes and the establishment of Japanese disease condition of hereditary angioedema
缓激肽裂解酶的评价及日本遗传性血管性水肿病况的建立研究
- 批准号:
26461493 - 财政年份:2014
- 资助金额:
$ 17.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Endothelial bradykinin receptors as therapeutic targets
内皮缓激肽受体作为治疗靶点
- 批准号:
290821 - 财政年份:2013
- 资助金额:
$ 17.63万 - 项目类别:
Operating Grants
Evaluating the potential of chemotherapy and bradykinin inhibitors combination therapy to increase drug distribution in solid tumors
评估化疗和缓激肽抑制剂联合治疗增加实体瘤药物分布的潜力
- 批准号:
297040 - 财政年份:2013
- 资助金额:
$ 17.63万 - 项目类别:
Miscellaneous Programs
Role of the Bradykinin Pathway in Craniofacial Development
缓激肽通路在颅面发育中的作用
- 批准号:
8725637 - 财政年份:2012
- 资助金额:
$ 17.63万 - 项目类别:
the bradykinin system in endometriosis
子宫内膜异位症中的缓激肽系统
- 批准号:
24791687 - 财政年份:2012
- 资助金额:
$ 17.63万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




